previous study, we have shown that human neonatal cardiosphere-derived cells outperform human adult cardiospherederived cells in their ability to functionally improve the ischemic myocardium in a rat MI model. 14 Resident cardiac stem/progenitor cells within the developing, maturing, or adult myocardium have been defined by a variety of cell markers (c-kit + , Sca-1, Abcg-2, Flk-1, and platelet-derived growth factor receptor [PDGFR]-A) and transcription factors (ISL1, NKX2.5, GATA4, and Wt-1). [15] [16] [17] The transplantation of c-kit + CPCs in patients with heart failure of ischemic cause (SCIPIO trial [Cardiac Stem Cell Infusion in Patients With Ischemic Cardiomyopathy]) improved heart function, reduced infarct size, and increased viable tissue mass. 18 A recent meta-analysis determined that in preclinical studies and animal models of MI, CPC treatment significantly improved the ejection fraction (EF) of the left ventricle. 19 These encouraging results have led to a new phase I clinical trial using a combination of c-kit + CPCs and mesenchymal stem cells in adult patients with ischemic heart disease (https://clinicaltrials.gov, NCT02501811). 20 Because transplanted c-kit + CPCs are not retained in the injured myocardium or do they differentiate into cardiomyocytes, it is generally agreed that c-kit + CPC-derived paracrine factors, rather than the cells themselves, stimulate yet-unidentified endogenous regenerative pathways, promoting myocardial regeneration and functional recovery. [21] [22] [23] [24] [25] Despite this notion of paracrine action by the c-kit + CPCs, a detailed analysis of the c-kit + CPCs secretome and its contribution to myocardial recovery has yet to be performed.
In the present study, to reflect a clinical setting, we evaluated the potential of human neonatal CPCs (nCPCs) and adult CPCs (aCPCs) and their total conditioned media (TCM) in a rodent MI model with functional outcomes. In vitro isolation and expansion of these cells revealed novel correlations between their growth and functional characteristics to their efficacy for myocardial recovery in vivo. We assessed the release of various paracrine factors previously implicated in post-MI myocardial functional recovery in vitro and in vivo. We performed an in-depth analysis of the protein composition of the CPC's secretome using label-free quantitative proteome analysis (HiRes LC-MS/MS) to evaluate the effect of aging on the protein component of secretome. In addition, we aimed to identify key upstream factors that can positively influence the protein composition of the CPC's secretome. Comparison of proteomic profiles in nCPC and aCPC TCM revealed significant differences in key signaling pathways and regulators involved in post-MI myocardial recovery. Heat-shock factor-1 (HSF1) emerged as one of the key upstream regulator critical for the maintenance of cellular metabolism, proliferation, and What Is Known?
• Transplantation of c-kit + cardiac progenitor cells (CPCs) into the myocardium leads to substantial recovery/regeneration of damaged heart tissue • Whether c-kit + CPCs directly contribute to new cardiomyocyte formation or induce endogenous repair mechanisms by secreting trophic paracrine factors remains unknown.
• The mechanisms of action by which CPCs recover injured myocardium, and the effect of chronological age on their ability to recover/regenerate injured myocardium has not been explored.
What New Information Does This Article Contribute?
• Neonatal CPCs (nCPCs) show robust in vitro proliferative capacity and are more effective than adult CPCs at recovering myocardial tissue and cardiac function when transplanted into the infarcted myocardium.
• A single injection of nCPC-derived total conditioned medium (complete secretome) is more effective than transplanted nCPCs or their exosomes.
• In-depth proteome analysis of the adult CPC and nCPC secretome indicates that heat shock factor-1 is an upstream regulator, which determines the composition and functionality of the nCPC secretome.
Although cardiac transplantation of CPCs rescues the infarcted myocardium and improves functional recovery, the mechanism underlying the beneficial effects of CPCs is not well understood.
Here, we demonstrate that CPCs derived from human neonatal hearts are significantly more effective than CPCs from older hearts at recovering injured myocardium after myocardial infarction. In addition, we show that a single injection of nCPCderived conditioned medium has a greater potential to rescue cardiac function and recover injured myocardium than nCPCs themselves. A deep comparative proteome analysis of the nCPC and adult CPC secretomes' suggested that the transcription factor heat shock factor-1 is one prominent pathway present in nCPCs. Our subsequent in vitro analyses revealed that heat shock factor-1 is responsible for the distinct proteome composition and superior functionality of nCPCs. These findings support a new mechanism to explain the variation in cardiac regenerative potential between neonates and adults, and point to novel therapeutic strategies for cardiac regeneration in adults. The conditioned media from nCPCs may be used as a starting point to develop the next generation of cell-free cardiac regenerative therapies.
Novelty and Significance
functional activity of CPCs. We conclude that the secretome is the functional unit of CPCs and that HSF1 is a major regulator of the composition and functionality of the CPC secretome.
Methods
A detailed section of experimental procedures and Materials and Methods is provided in the Online Data Supplement and includes detailed methodology on human tissue collection and clinical diagnosis (Online Table I ), generation of CPCs, telomere and senescence studies, flow cytometry, cloning potential of CPCs, preparation and fractionation of conditioning medium, isolation of exosomes and protein identification using high-resolution LC-MS/MS followed by interactome analysis. Real-time-polymerase chain reaction (PCR) analysis, confocal microscopy, immunoblotting, induction of MI, cell transplantation, heart function, and histological analysis were performed as described previously. 26, 27 Statistical analysis of data, HSF1-knockdown in nCPCs, and details of the plasmid used for overexpression of HSF1 in aCPCs is also included in the Online Data Supplement. Antibodies used in this study are listed in Online Table II .
Results

Cell Surface Markers and Clonogenic Capacity of CPCs
Biopsies of human cardiac tissue were obtained from the right atrial appendage at the time of cardiac surgery from neonates (<1 month) and adults (>40 years). Multiple forms of congenital heart diseases were present in the neonates (Online Table  I ). Adults were undergoing coronary artery bypass grafting for severe atherosclerotic disease. Neonatal and adult c-kit
− CPCs, nCPCs and aCPCs, respectively, were isolated from right atrial appendage biopsies using our previously described protocol involving explant plating, immune-bead selection, and expansion. 26, [28] [29] [30] [31] All tissue specimens, even those weighing between 20 and 40 mg, generated c-kit + CPCs, which were successfully grown beyond 30 days and, on average, yielded >18×10 6 cells. At passage 3 (P3), nCPCs and aCPCs had similar cellular morphologies and were negative for expression of hematopoietic markers (CD34 and CD45), endothelial markers (CD31; PECAM-1 [platelet endothelial cell adhesion molecule-1]), mast cell markers (tryptase), certain cardiomyocyte lineage-specific transcription factors (GATA4 and ISL1), and embryonic stem cell markers (SSEA3 and SSEA4). They exhibited equivalent expression of c-kit, mesenchymal stem cell markers (CD105 and CD90), and the cardiomyocyte lineage-specific transcription factor Nkx2.5 ( Figure 1A ; Online Figure IA through IL). In contrast, nCPCs expressed 3.5-fold higher levels of the proliferation marker Ki67 when compared with aCPCs (Online Figure IM) . These results suggest that, although the 2 c-kit + CPC populations were morphologically and biochemically similar at P3, the proliferative potential of nCPCs was superior to that of aCPCs.
The proliferative potential of stem/progenitor cells is directly linked to the number of daughter cells generated. 32 Therefore, we compared the clonogenic potential of nCPCs and aCPCs. Magnetic bead-sorted aCPCs and nCPCs were plated in single-well Terasaki plates. A total of 240 wells were seeded for each of the nCPCs and aCPCs. Wells with >1 cell were excluded from the analysis. Although nCPCs and aCPCs were both capable of generating homogenous populations of CPCs, spindle-shaped clones were present in nCPCs after 1 week, whereas the aCPCs required a month to form colonies of 5000 to 7000 cells (Online Figure IN) . Sixty-eight wells with nCPCs and 76 wells with aCPCs were detected with 1 cell per well. Forty aCPC clones of 76 wells (52.6%) attached and replicated up to ≈100 to 200 cells (6-8 population doubling levels [PDLs] : total number of times the cells in the population have doubled since their primary isolation in vitro 33 ) before undergoing growth arrest. Five aCPC clones (6.6%) actively proliferated to give rise to colonies of ≈5000 to 7000 cells (12) (13) (14) and then underwent growth arrest. No aCPC clones could proliferate >14 PDLs. Eleven nCPC clones (16.2%) gave rise to colonies of 100 to 200 cells (6-8 PDLs) before undergoing growth arrest. Eight nCPC clones (11.7%) actively proliferated to 5000 to 7000 cells (12) (13) (14) . Of the remaining nCPC clones, at least 22 (32.4%) continued to replicate up to ≈33 million cells (25 PDLs) without reaching replicative senescence. Genetic diversity did not affect the proliferation rate of nCPCs. Thus, the cloning efficiency of nCPCs is ≈2.5-fold higher than that of aCPCs ( Figure 1B ).
Growth Properties and Functional Characteristics of nCPCs and aCPCs
Ex vivo expansion of CPCs is necessary for generating sufficient cell numbers for clinical applications. Growth properties and functional characteristics of these cells during their expansion provide relevant metrics that could reflect their functionality after transplantation in a rodent MI model. Therefore, a series of growth and functionality assays were performed at passages 3 (P3) and 8 (P8) for the aCPCs and nCPCs.
The pluripotent genes OCT3/4, NANOG, KLF4, and SOX2 maintain the self-renewing and multipotent state of these progenitor cells. 12, 34, 35 Expression patterns of these genes were determined at different P3 and P8 by quantitative RT-PCR ( Figure 1C ). Both CPC populations expressed all 4 genes. OCT3/4, c-kit + and KLF4 expressions were similar between the 2 CPC populations at P3; however, by P8, the expression of all 3 genes was significantly decreased in aCPCs when compared with nCPCs. In addition, NANOG and SOX2 expression were significantly different between nCPCs and aCPCs at P3 and that trend was still evident at P8.
Expression of c-kit + may be critical for the functional activity of c-kit + CPCs. 28, 36 The level of c-kit protein expression was determined from P3 to P8 in both CPCs. Flow cytometric analysis showed that nCPCs retained c-kit expression with increasing passage from P3 to P8, whereas aCPCs showed a significant decrease in c-kit expression with increasing passage numbers ( Figure 1D ; Online Figure IIA) . A significant reduction in c-kit expression (17.25%) occurred after P5 in aCPCs. Recently, lineage tracing techniques have suggested that c-kit + CPCs in the murine heart are endothelial cells and not cardiomyocytes because of their CD31 (PECAM-1) expression. 37 Immunoblot analysis using our human nCPCs and aCPCs failed to detect the presence of CD31 (Online Figure IIB) .
Enlargement of cell size has been correlated with aging, limiting life span, 38 cellular activity, and proliferation, which subsequently leads to senescent cultures. 39 Immunofluorescent staining using wheat germ agglutinin showed ≈4-fold enlargement in the size of aCPCs at P8 when compared with P3 ( Figure 1E ; Online Figure IIC) . The nCPCs maintained a higher proliferative rate, which remained unaffected by increasing passage, whereas aCPCs gradually lost their proliferative rate, as measured by population doubling (cumulative fold change) at every increasing passage ( Figure 1F ).
Shortening of telomere length is also a major indicator of stem/progenitor cell aging 40, 41 and telomere depletion beyond a threshold elicits a DNA damage response that induces cellular senescence. We measured changes in telomere length with increasing passage number in aCPCs and nCPCs. Relative to aCPCs, nCPCs showed a significantly higher fraction of telomere hybridization foci ( Figure 1G ). The telomere lengths of nCPCs and aCPCs at P3 and P8 were quantified using quantitative fluorescence in situ hybridization 42 ( Figure 1H ; Online Figure IID) . At P3, nCPCs showed significantly longer Figure IIC . F, Cellular growth potential of nCPCs and aCPCs recorded as cumulative population doubling (n=5). G, Telomeres in nCPCs and aCPCs nuclei (red dots) at P3 and P8 were identified by using quantitative fluorescence in situ hybridization (Q-FISH). H, Telomere length in nCPCs and aCPCs at P3 and P8 identified using flow FISH. A significant difference was observed in the telomere length of aCPCs at P3 and P8. Data are analyzed by t test or Mann-Whitney U test using GraphPad software and represented as mean±SEM. P=0.0585, n=5. See also Online Figure IID . I, Quantification of apoptosis for TUNEL+ cells in nCPCs and aCPCs after hydrogen peroxide stress (see also Online Figure IIIB) . All data are represented as mean±SEM (n=5-8), *P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001. Data are analyzed using 2-way ANOVA followed by Bonferroni post-tests (B), 1-way ANOVA followed by Kruskal-Wallis test (n=6), t test followed by Mann-Whitney analysis (I; n=6) and Wilcoxcon matched-pairs signed-rank test. March 3, 2017
telomere lengths compared with aCPCs. At P8, nCPCs retained their telomere length, whereas aCPCs had significantly decreased telomere length. Telomere length was found to be associated with cell senescence as at P8 the majority of the aCPCs were senescent, as determined by β-gal activity, while no β-gal activity was observed in nCPCs at P8 (Online Figure  IIE and IIF). Consistent with these results, nCPCs had minimal expression of the senescence-associated protein p16
INK4a
, whereas aCPCs had significantly higher p16
INK4a expression (Online Figure IIIA) .
Removal of reactive oxygen species is an important mechanism for cell survival and prevention of cellular senescence, 43 and stem/progenitor cells are resistant to oxidative stress. 44 CPCs were subjected to oxidative stress induced by hydrogen peroxide treatment for 16 hours, after which apoptosis was determined by terminal deoxynucleotidyl transferase dUTP nick-end labeling assay. The nCPCs were significantly more resistant to hydrogen peroxide-induced apoptosis than aCPCs (Online Figure IIIB ; Figure 1I ).
The majority of aCPCs stopped growing by P8, which may reflect an increase in differentiation of these aCPCs from P3 to P8. Quantitative RT-PCR of aCPCs at P3 and P8 showed that no significant changes in the basal expression levels of markers for endothelial cells (CD31 and VEZF1), cardiomyocytes (TnnT2 and GATA4), and cardiac fibroblasts (DDR2). In contrast, NKX2.5 expression was significantly decreased by P8, suggesting that during increasing ex vivo expansion, aCPCs were losing their cell identity and commitment as CPCs (Online Figure IIIC) .
Taken together, these results show that at least 4 different growth properties-loss of c-kit + expression, reduced cell division, telomere shortening, and induction of senescence markers-were exhibited by aCPCs compared with nCPCs. Furthermore, the progressive, time-dependent nature of these changes (from P3 to P8) suggests that chronological age affects the intrinsic growth properties and functional characteristics of human c-kit + CPCs.
CPCs Improve Cardiac Function and Attenuate Left Ventricular Remodeling
To evaluate whether the improved growth properties and functional characteristics of nCPCs are associated with an improved ability to recover myocardial function in vivo, we transplanted nCPCs (P3) and aCPCs (P3) in a rodent model of acute MI and evaluated ventricular function after cell transplantation. Because the c-kit + CPCs express the human nuclear antigen, this study also allowed tracing of transplanted human cells within the rodent myocardium. 14, 27 The consistency of our MI model was verified for the each treatment group by performing echocardiography at baseline and 24 hours after MI. 26 After ligation of the left anterior descending artery, 1 million aCPCs or nCPCs, or cell-free Iscove Modified Dulbecco Medium (control) was injected into the myocardium of the left ventricle. Transthoracic M-mode images of the LV in the parasternal short-axis view were obtained at the level of the papillary muscles using high-resolution ultrasound (Vevo 2100; VisualSonics, Toronto, Canada) equipped with a 20-MHz scan head. Data were calculated from 5 cardiac cycles according to the generally accepted formula. 45 The EF was similar among the 3 groups at baseline and 24 hours post-MI, indicating that MI surgeries were performed consistently among all groups ( Figure 2E ). Transplanted aCPCs or nCPCs significantly improved cardiac function relative to the control injection, as evidenced by recovery of EF and fractional shortening ( The presence of human CPCs within the rodent myocardium was tracked using immunofluorescence for their expression of human nuclear antigen. There was a similarly low engraftment of transplanted nCPCs or aCPCs in the periinfarct zone after 4 weeks ( Figure 2I ). Quantification of the absolute number of retained human cells in rodent myocardium was performed using a highly sensitive and accurate real-time PCR method for human leukocyte antigen. 21, 46 One million nCPCs or aCPCs were injected into the rat myocardium and after 5 minutes, approximately half of the number of nCPCs or aCPCs were present in the infarcted zone of LV region. Significantly more nCPCs were retained in the host myocardium as analyzed after 7 and 14 days post-cell transplantation when compared with aCPCs (by ≈3.5-fold; Online Figure IVD ). To evaluate whether CPC treatment influences post-MI myocardial inflammation, we stained the infarcted zone in myocardial sections for the macrophage infiltration marker CD68. Myocardial sections from rats having received nCPCs had significantly fewer macrophages compared with sections from rats having received aCPCs (Online Figure  IVE) . The frequency of rat cardiomyocyte cycling in the periinfarct region, determined by costaining of α-sacromeric actin and Ki67, was increased with nCPC compared with aCPC treatment ( Figure 2J ). Both aCPC and nCPC treatments augmented the preservation/formation of neovessels (isolectin B4, IB4) and arterioles (α-smooth muscle action), albeit significantly higher after nCPCs treatment than aCPCs treatment ( Figure 2K and 2L). Although neovessel formation spanned the length of the infarct, the greatest differences were seen in the midinfarct regions. In addition, the number of arterioles was significantly higher in anterior and midinfarct zones with nCPCs than with aCPCs treatments. These data showed that the improved growth properties and functional characteristics 
Expression of Paracrine Factors by nCPCs and aCPCs
The significant myocardial recovery despite low levels of retention of transplanted CPCs in rat myocardium suggests that paracrine factors secreted by these cells, rather than their differentiation, may play a major role in the improvement of cardiac function observed after CPC transplantation. We therefore compared the secretion levels of 8 paracrine factors within the nCPC and aCPC conditioned medium that have been previously suggested to play a role in stem/progenitor cell-mediated repair. These 8 factors were as follows: hepatocyte growth factor (HGF) and insulin-like growth factor-1 (IGF-1; known to promote cardioprotection, inhibit apoptosis, and stimulate growth [47] [48] [49] [50] ), stem cell factor (SCF) and stromal cell-derived factor-1 (SDF-1α; known to improve stem cell function, recruitment, and proliferation [51] [52] [53] ), angiopoietin 1 (ANG-1), 47, 51 vascular endothelial growth factor A (VEGFA), 47, 49, 52, 54, 55 PDGFB, 47, 49 and b-fibroblast growth factor-1 49, 51 (known to promote angiogenesis). ELISA-based quantitative analysis of these 8 paracrine factors in TCM from aCPCs and nCPCs revealed that HGF, SCF, SDF-1α, ANG-1, VEGFA, PDGFB, and b-fibroblast growth factor-1 are secreted at higher levels by nCPCs compared with aCPCs ( Figure 2M ). IGF-1 levels were not significantly different between the TCM derived from 2 CPC populations.
Paracrine secretion by transplanted CPCs was also evaluated in vivo. Myocardial sections were obtained at 24 and 72 hours post-transplantation, and the presence of these selected paracrine factors was determined by immunofluorescence. Control myocardial sections (Iscove Modified Dulbecco Medium injection) showed little to no presence of the 8 paracrine factors at 24 hours or 72 hours post-MI (Online Figure  V) . In contrast, myocardial sections from transplanted nCPCs showed clear staining for VEGFA, HGF, SCF, SDF-1α, and ANG-1 but not for IGF-1, PDGFB, or b-fibroblast growth factor-1. Myocardial sections from transplanted aCPCs stained only for VEGFA and ANG-1 (Online Figure V) . After 72 hours post-MI, MI sites from nCPCs treatment continued staining for VEGFA, HGF, SCF, and ANG-1 but not for SDF-1α, whereas myocardial sites containing aCPCs continued to stain for ANG-1 and VEGFA, but not for other paracrine factors ( Figure 3A ).
Retention and Proliferation of Transplanted CPCs in Rat Myocardium
The higher levels of paracrine factor secretion by nCPCs may be related to increased retention and proliferation in the rat myocardium when compared with aCPCs. 56 The numbers of CPCs retained in the myocardium after injection was determined by staining myocardial sections for human nuclear antigen expression. At 24 hours post-MI, aCPCs and nCPCs were detected at equal numbers ( Figure 3B and 3C) . However, by 72 hours post-MI, transplanted nCPCs were retained in the peri-infarcted infarcted region by >10-fold when compared with transplanted aCPCs (Online Figure IVD) . The proliferative potential of transplanted CPCs within the ischemic myocardium was determined by costaining of myocardial sections with the proliferative marker, Ki67, and the human mitochondria antigen. Among retained CPCs, transplanted nCPCs had a 13-fold increase in the number of Ki67 + / human mitochondria antigen + cells compared with aCPCs, suggesting nCPCs maintained a greater proliferative capacity ( Figure 3D and 3E). These data suggest that improved cellular retention and proliferation of nCPCs compared with aCPCs ( Figure 3C ; Online Figure IVD ) contribute to prolonged paracrine factor secretion by nCPCs ( Figure 3A ; Online Figure  V ) and the improved capacity of nCPCs to induce myocardial recovery in vivo. Taken together, these data suggest that transplanted nCPCs are retained and proliferate for a longer time in the infarcted myocardium and are more effective when compared with aCPCs to promote remodeling of the infarcted myocardium.
Myocardial Remodeling by CPC TCM
To determine whether paracrine factors secreted by CPCs contribute toward the cardioprotective properties of CPCs, we tested CPCs' TCM (nCPCs-CM, nCPC-derived TCM [nTCM] and aCPCs-CM, aTCM) in several in vitro and in vivo functionality assays. First, we tested the ability of TCMs to promote angiogenesis using human microvascular endothelial cells (HMECs) in vitro. HMECs formed long and complex mature tube networks in the presence of nTCM or HMECscomplete medium when compared with aTCM ( Figure 4A ; Online Figure VIA) . In a direct dose-dependent comparison, nTCM induced HMECs to form longer endothelial tubes when compared with aTCM (Online Figure VIB) .
We next determined the antioxidative effect of nTCM and aTCM on neonatal rat cardiomyocytes. Treatment of neonatal rat cardiomyocytes with H 2 O 2 in the presence of nTCM significantly decreased the expression of early apoptosis marker annexin V, when compared with aTCM ( Figure 4B ; Online Figure VIC ). Furthermore, nTCM stimulated proliferation of neonatal rat cardiomyocytes as indicated by the increasing number of BrdU (5-bromo-2'-deoxyuridine)-positive cells relative to baseline or in the presence of aTCM after 72 hours ( Figure 4C ; Online Figure VID) . Taken together, these results indicate that nTCM stimulated angiogenesis, decreased oxidative stress-induced apoptosis, and promoted cardiomyocyte proliferation in vitro. Figure 2 Continued. expression, and (L) arterioles marked by α-smooth muscle action (α-SMA) expression in different heart regions. Nuclei were labeled with 4′,6-diamidino-2-phenylindole (DAPI; blue) in all images. M, ELISA performed on nCPCs (P3)-and aCPCs (P3)-derived total conditioned medium (TCM). All the data are represented as mean±SEM, *P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001. Data are analyzed using 2-way ANOVA followed by Bonferroni post-tests (E-H, n=8-13), t test followed by Mann-Whitney analysis (I and J, M; n=6) and 2-way ANOVA followed by Tukey post-test (K and L; n=10). See also Online Figure IV . ANG-1 indicates Angiopoietin 1; bFGF, b-fibroblast growth factor; CM, cardiomyocytes; EF, ejection fraction; FAC, fractional area change; HGF, hepatocyte growth factor; IGF, insulin-like growth factor; PDGFB, platelet-derived growth factor sub unit B; SCF, stem cell factor; SDF, stromal cell-derived factor; and VEGF, vascular endothelial growth factor. To determine the contribution of CPCs-TCM in myocardial recovery in vivo, we injected nTCM or aTCM derived from 1 million CPCs in the myocardium of post-MI rats and studied their effects in ischemic myocardial recovery. The protein concentration was found to be higher in the secretome of nCPCs than in the same number of aCPCs (Online Figure VIIB) . A single injection of nTCM significantly recovered the EF and fractional shortening and reduced the end-systolic volume and end-diastolic volume in comparison to controls ( Figure 4D  through 4G ). Interestingly, a single injection of nTCM improved myocardial function more than injection of aTCM, and myocardial recovery persisted after 4 weeks post-MI. The density of neovessels and arterioles in the anterior and midinfarct region was greater in nTCM-treated myocardium than in controls and aTCM (Figure 4H and 4I; Online Figure VIIA) . These results indicate that injection of cell-free nTCM is more efficacious in recovering the infarcted myocardium than nCPC injection. To establish whether proteins in nTCM are necessary for angiogenesis, HMECs were grown on Matrigel with reduced growth factors in the presence of nTCM or heat-inactivated nTCM (95°C for 10 minutes). HMECs formed significantly longer tubes in the presence of nTCM, but this ability was lost in heatinactivated nTCM ( Figure 4J and 4K) , suggesting proteins to be critical for the biological activity of nTCM. To determine whether exosomes are critical for the biological activity of TCM, exosomes were isolated from nTCM with high degree of homogeneity using size exclusion chromatography (schematic representation in Online Figure  VIIC , also see Online Figure VIIIA and VIIIB). Fraction 6 contained a homogenous population of exosomes (neonatal CPC-derived exosomes [nEXO]), whereas fractions 15 to 17 were exosome-free (nEF) but enriched in proteins as quantified by nanosight analysis and verified for CD63 expression by fluorescence-activated cell sorter (Online Figure  VIIIC through VIIIE) . Endothelial cells internalized labeled exosomes from fraction 6 confirming the biological activity of exosomes (Online Figure IXA) . nTCM significantly enhanced both endothelial tube formation (Online Figure IXB ; Figure 5A ) and wound wound-healing process after 22 hours (Online Figure IXC; Figure 5B) when compared with nEXO fraction and nCPC-derived exosomes (free fraction). The nEXO fraction or nCPC-derived exosomes (free fraction) significantly enhanced tube formation and wound-healing process when compared with the negative control, but these 2 fractions had no significant difference between themselves. VEGFA, SCF1, and SDF-1α were significantly concentrated in nCPC-derived exosomes (free fraction), angiopoietin 1 and PDGFB were significantly concentrated in the nEXO fraction, whereas HGF1 and IGF-1 were not different between the 2 fractions ( Figure 5C ) as quantified by ELISA. These results imply that the cardioprotective proteins are present in the nTCM. These proteins are distributed as independently secreted proteins and exosomal cargo, whereas only selected proteins are within the nEXO. To further investigate these findings in vivo, a comparative study was performed with nTCM and nEXOs derived from 1 million nCPCs of the same biological replicates. A single injection of nTCM significantly recovered the EF and fractional shortening in comparison to injected nCPCs, nEXOs, or Iscove Modified Dulbecco Medium as seen on post-MI day 7 and persisted on post-MI day 28 in the rodent model ( Figure 5D and 5E). Masson trichrome staining of heart sections taken on post-MI day 28 indicated that nTCM-treated myocardium had significantly decreased fibrosis when compared with nCPC-or nEXO-treated animal groups ( Figure 5F ; Online Figure IXE ). This study also showed that injected nCPCs and nEXOs were comparable in functionally recovering the myocardium. The density of neovessels and arterioles in the anterior and midinfarct region was significantly greater in the nTCM-treated myocardium than in both the nCPCs and nEXOs (Online Figure IXD ; Figure 5G and 5H). Collectively, these results showed that the nTCM had superior functional activity when compared with cells, exosome-free fraction of the nTCM, or exosome therapy alone.
In-Depth Proteomic Analysis of the CPC Secretome
Liquid chromatography-tandem mass spectrometry (LC-MS/ MS) provided an in-depth quantitative analysis of the proteomes of TCMs from nCPCs and aCPCs, including the exosome fraction. TCM was prepared from 5 different biological replicates of nCPCs and aCPCs. Immunoblot analysis verified the integrity of the isolated proteins for GAPDH, Calnexin, VEGFA, and HSP70 (Online Figure XA and XB) . TCM samples were prepared for LC-MS/MS analysis using filter-aided sample preparation protein digestion protocol. The resulting peptides were analyzed in quintet biological replicates run in duplicate by LC-MS/MS using a NanoAcquity LC system coupled to a hybrid quadrupole-orbitrap instrument providing high-resolution and accurate mass detection of peptides. To compare relative expression, label-free quantification of the MS data and statistical analysis was performed in the MaxQuant 57 and Perseus (http://www.perseus-framework. org/) environment.
Normalizing to cell number at passage (P3), the nTCM contained higher protein concentration (1.83±0.122-fold) as compared with aTCM (Online Figure VIIB) . Principal component analysis segregated the nTCM and aTCM groups and showed greater protein similarities among the nTCM biological replicates, but more protein variance among the aTCM biological replicates ( Figure 6A ). A total of 804 proteins in the nTCM and 513 proteins in the aTCM were identified ( Figure 6B ), including 372 proteins in the nTCM and 81 proteins in aTCM that were exclusively expressed (Online Tables IV through VI) . Among the 434 shared proteins, 93 proteins were expressed highly (>2-fold, false detection rate [FDR]-adjusted P<0.05) in the nTCM whereas 11 were highly expressed in the aTCM. The remaining 330 proteins did not show any significant differences (the most highly expressed shared proteins are presented in Online  Table VII ). Heat-map demonstrated the differential protein expression profile between nTCM and aTCM ( Figure 6C ). The proteins with >2-fold changes (Online Figure XC , FDR-adjusted P value <5%) were annotated (KEGG database) for Gene Ontology Biological Process (Online Figure  XD) , molecular function ( Figure 6D ; Online Table III) , and cellular compartmentalization (Table) . Consistent with our data demonstrating that nCPCs promote myocardial angiogenesis in the MI model, network graphical analysis of molecules and pathway enrichment analysis further demonstrated that the nTCM secretome was actively involved in myocardial recovery by significantly regulating angiogenesis-related pathways when compared with aTCM (Online Figure XE) . Functional analyses were generated through the use of Ingenuity Pathway Analysis (IPA; Qiagen Redwood City, CA; www.qiagen.com/ingenuity) software that demonstrated a total of 46 pathways that were significantly upregulated in nTCM (Online Table VIII ), including p70S6K, mTOR signaling, telomere extension, ERK/MAPK (extracellular signal-regulated kinases/mitogen-activated protein kinases), HIF1α (hypoxia-inducible factor 1-alpha), HIPPO, VEGF, HMGB1 (high-mobility group box 1), CDK5, PAK, and PI3/AKT signaling (FDR-adjusted P<0.05). A similar IPA analysis identified 6 pathways that were upregulated in aTCM (Online Table IX ), including the complement system, inhibition of MMPs (matrix metalloproteinases), fibrosis, and LXR/RXR (liver X receptor/retinoid X receptor) activation (FDR-adjusted P<0.05), and the canonical pathways shared between aTCM and nTCM (Online Table X ). Further use of the IPA targeting canonical pathways involved in cardiovascular development and function identified 74 proteins of interest in the nTCM and 41 proteins in the aTCM. A gene ontology cellular compartment analysis predicted that 70% proteins were secreted in the exosomal cargo of nTCM, whereas 44% proteins were secreted in the exosomal cargo of aTCM ( Figure 6E and 6F) . About cellular level functions, nTCM significantly favored cellular proliferation, cellular movement, protein metabolism, nucleic acid metabolism, energy production, antioxidation, inflammatory response, nucleic acid metabolism, and vitamins and mineral metabolism, whereas aTCM significantly involved in tissue modulation, cellular compromise, organism survival, small molecule biochemistry, hematopoiesis, and carbohydrate metabolism (Online Figures XF through XH and XI) .
To identify a mechanism for the nTCM's superior myocardial remodeling abilities, evaluation of the nTCM protein data set revealed that 3 heat-shock proteins (HSPs), including hsp70, were among the top 8 highly represented proteins (Online Table XI ). Furthermore, 8 of 46 canonical signaling pathways that were upregulated in nTCM (refer to Online Table VIII) were affected by HSPs (Online Table XII) . Gene ontology molecular function analysis identified HSPs as significantly highly represented only in nTCM ( Figure 6G ). Immunoblot analysis demonstrated a significantly higher protein expression of hsp70 present in nCPCs when compared with aCPCs from 2 biological replicates ( Figure 6H) . Analysis of the upstream regulators of nTCM and aTCM in IPA (Online Tables XIII through XIV) identified the transcription factor HSF1, the master HSP regulator (P=1.88×10 −16 ) was predicted to affect 19 networks and 150 genes (Online Tables XIII Figure 6 . In-depth proteomic analysis of the secretome derived from neonatal cardiac progenitor cells (nCPCs) and adult CPCs (aCPCs). A, Principal component analysis of nCPC-derived total conditioned media (nTCM; blue) and nCPC-derived TCM (aTCM; red), where each dot represents one of 5 independent biological replicates. B, Venn diagram depicting unique, shared, and nonredundant (Contiuned ) and XV). An interactive network analysis in IPA showed that HSF1 regulated the expression of HSP70, HIF1α, HMGB1, STAT3, NFκB, which are among the highly expressed canonical signaling pathways in nTCM ( Figure 6I ; Online Table  XV ). The heat-shock response, which protects cells from the proteotoxic environment and maintains protein homeostasis through HSPs, is critical for survival of all organisms and is essentially regulated by HSF1. 58 Knockdown of HSF1 protein using siRNA in nCPCs significantly reduced the protein expression of 2 representative paracrine factors VEGFA and SCF1 as observed by immunoblot analysis ( Figure 6J ), suggesting that HSF1 is one of the upstream regulators of the cardioprotective proteins in the secretome of CPCs. Scrambled siRNA had no effect on the expression of HSF1 or the analyzed paracrine factors in nCPCs.
HSF 1 Regulates the Functional Potential of the Secretome of CPCs
To increase the efficacy of regenerative therapies to treat ischemic myocardium, stem cells have been genetically engineered to overexpress individual paracrine factors including VEGFA, ANG-1, SDF-1α, HGF, HSP20, and Akt. [59] [60] [61] [62] [63] [64] [65] Our in silico analysis and knockdown experiments ( Figure 6G through 6J) identified HSF1 as one of the upstream master regulators and candidate protein whose modulation could regulate the functional potential of the CPC secretome. To verify these in silico predictions, we knocked down HSF1 in nCPCs and overexpressed HSF1 (pcDNA4/TO-HSF-HA; Online Figure XIIA) in aCPCs, as shown in Figure 7A . These modifications were assessed in terms of their effect on (1) cellular properties (growth potential, cellular metabolism, and resistance to oxidative stress) of nCPCs and aCPCs, (2) the functional potential of TCM, and (3) the functional potential of the exosomes and soluble components of the secretome derived from nCPCs and aCPCs. Knockdown of HSF1 in nCPCs significantly impaired the growth potential after 96 hours of siRNA transfection, caused morphological changes nCPCs (Online Figure XIIB) , significantly reduced their metabolic activity, and significantly reduced their resistance to oxidative stress (Figure 7B and 7C; Online Figure XIIC ). Although overexpression of HSF1 in aCPCs did not significantly affect their growth pattern ( Figure 7D ), HSF1-overexpression significantly enhanced the metabolic activity and resistance to oxidative stress ( Figure 7E ; Online Figure XIID ; also see Figure 1F and 1I; Online Figure IIIB) . We further analyzed the expression of several direct and indirect targets of HSF1 in CPCs ( Figure 6I ) known to affect the secretome. Quantitative PCR analysis showed that after the knockdown of HSF1 (>85%) in nCPCs (Online Figure  XIIE, left) , the expression of HIF1α, VEGF, and HSP genes (HSF2, HSP90AB, HSP70, and HSPD1) was all significantly reduced (by >55%), whereas the overexpression of HSF1 (≈6-fold) in aCPCs (Online Figure XIIE, right) significantly enhanced the expression of HIF1α (≈2.1-fold), HSF2 (≈2.4 fold), HSP90AB1 (≈2.4 fold), VEGFA (≈3.5 fold), HSP70 (≈2.9 fold), and HSPD1 (≈2.6 fold). The changes in cellular function and gene expression after knockdown and overexpression of HSF1 in nCPCs and aCPCs, respectively, were reflected in the functional potential of their TCM as the proangiogenic potential of nTCM was significantly reduced (≈1.7-fold) after HSF1-knockdown, whereas the angiogenic potential of aTCM increased significantly (≈1.2-fold) after overexpression of HSF1 (Figure 7F through 7G ; Online Figure XIIIA) . A similar effect on the functional potential of TCM was observed in a subsequent wound-healing assay (Figure 7H and 7I; Online Figure XIIIB) . These functional analyses established that knockdown of HSF1 in nCPC caused nTCM to lose its functional superiority to aTCM, whereas the overexpression of HSF1 in aCPCs improved their angiogenic and migratory potential. CPC-derived exosomes also contributed to the myocardial functional recovery potential of these cells. HSF1-knockdown in nCPCs resulted in a significant reduction in numbers of exosomes, whereas HSF1-overexpression in aCPCs increased exosome production from aCPCs ( Figure 7J ). Our IPA analysis (Figure 6E and 6F; Online Figure XE) identified several angiogenic and cardioprotective proteins as VEGF-, angiopoietin 1, SDF1α, and PDGFB, present in the CPC secretome. aTCM indicates adult cardiac progenitor cell-derived total conditioned media; N, number of proteins; and nTCM, neonatal cardiac progenitor cell-derived total conditioned media. Figure 6 Continued. identified proteins between the nTCM and aTCM. C, Heat-map indicating protein distribution in nCPCs and aCPCs, as determined by quantitative proteomics. Hierarchical clustering is shown, clusters of positive (red; upregulated) and negative (green; downregulated) correlations showed the log 2 fold expression changes. D, Proteins identified in nTCM and aTCM were further classified in different groups according to their reported molecular functions and biological properties. The x-axis shows protein groups, organized according to their functions, and the y-axis represents the relative number of proteins. E, Ingenuity pathways analysis (IPA) analysis highlighting the roles of 74 unique nTCM proteins in cardiovascular system development and function. F, IPA analysis highlighting the roles of 41 unique aTCM proteins in cardiovascular system development and function. G, The proteins with log 2 fold changes of ≥1 and ≤−1 identified in nTCM and aTCM were further analyzed for their roles in heat shock proteins. H, Immunoblot analysis of HSP70 expression levels in 2 nTCM samples (N1 and N2) as compared with 2 aTCM samples (A1 and A2). I, IPA network analysis demonstrates heat shock factor (HSF)-1 as an upstream regulator of several key pathways. J, Immunoblot analysis of expression levels of HSP70, HSF1, vascular endothelial growth factor (VEGF) A, and stem cell factor (SCF) after knockdown of HSF1. See also Online Figures X and XI.
We analyzed whether HSF1-knockdown or overexpression altered the secretion of these proteins by nCPCs and aCPCs, respectively. VEGFA, angiopoietin 1, SDF1α, and PDGFB were significantly reduced in nTCM after HSF1-knockdown in nCPCs, whereas the amount of these proteins was significantly enhanced in aTCM after HSF-overexpression in aCPCs (Figure 7K through 7N) . Together, these results confirm that HSF1 not only is essential for the maintenance of biochemical properties of CPCs but also regulates the quality of their secretome. 
Discussion
The present study establishes TCM as the functional unit endowing CPCs with the ability to recover myocardial function in a rodent MI model. Chronological age directly influences nCPCs' proliferation, cellular retention, more potent secretome, and better functional recovery after MI. In a comparative analysis, nTCM outperformed nCPCs, exosomes derived from nCPCs, and the exosome-free fraction of nTCM in the induction of endogenous repair mechanisms that manifest as decreased myocardial fibrosis, increased neovessel density, decreased inflammation, and stimulation of cardiomyocyte proliferation. Quantitative proteomic analysis of TCM from aCPCs and nCPCs identified multiple protein data sets, the meaning of which was further refined by the use of IPA software to examine canonical signaling pathways for myocardial recovery. One of the most highly predictive mechanisms was the HSP pathway, and inhibition of HSF1 expression in nCPCs significantly reduced the amount of secretome, thereby impairing its capacity to promote myocardial recovery. A deep proteomic analysis revealed both detailed and global mechanisms that contribute to CPC's functional activity as affected by chronological aging.
Chronological age is a major determinant of the growth reserve and functional effectiveness of ex vivo expanded c-kit + CPCs. Our data showed that 3 different senescence markerstelomere length, p16
INK4a expression, and β-galactosidase-are more prominent, with increasing passage numbers, during in vitro expansion of aCPCs than of nCPCs. Furthermore, more robust proliferation and more intense paracrine factor secretion were observed with transplanted nCPCs compared with aCPCs in vivo 3 days after the MI. These findings suggest that nCPCs have a more robust growth reserve, independent of passage number, compared with aCPCs, and the secretomecentric results stand in contrast to a previous study that suggested the correlation of increased growth potential of CPCs with cardiomyocyte differentiation of these cells in vivo. 66 We and others have demonstrated that this may not be true, as CPCs do not differentiate into large numbers of cardiomyocytes in vivo. 37, 67, 68 Also, a recent study reported that advanced chronological age increases the presence of senescence markers in human CPCs; however, the study was limited because no direct relationship was established between aging and myocardial functional recovery. 12 Our results support the notion that the growth properties of the CPCs correlate, not with an increased propensity for cardiomyocyte differentiation, but with a more robust secretome able to activate endogenous myocardial recovery and repair mechanisms.
In this study, we evaluated candidate paracrine factors secreted by the c-kit + CPCs after their transplantation in the infarcted myocardium. Previous studies have examined paracrine factor secretion by different stem/progenitor cells in vitro and assumed that the same paracrine factors are expressed after injection of c-kit + CPCs in vivo. 69 Others examined either paracrine factors in the entire infarcted heart after MI or only one selected paracrine factors. 70 This is the first study to comprehensively examine the secretome of human CPCs and analyze the paracrine factors in a discovery-based approach rather than after a candidate-based approach. We first established in vitro profile of candidate paracrine factor secretion and then determined their in vitro expression levels in the infarcted myocardium in vivo. A similar study determined the temporal secretion of paracrine factors by different transplanted rodent stem cell types, including cortical bone-derived stem cells and c-kit + CPCs, within the infarcted myocardium. 71 This study revealed a very different profile of paracrine factors secretion by rodent c-kit + CPCs in comparison to our human c-kit + CPCs, highlighting the importance of studying human c-kit + CPCs for clinical applications. Specifically, our study showed that transplanted nCPCs secreted factors involved in angiogenesis (VEGFA and ANG-I 47, 49, 52 ); cardioprotection, growth, survival, and migration of CPCs and cardiomyocytes (HGF 47, 48, 50 ); and stem cell recruitment (SCF and SDF-1α) within the myocardium and did not express PDGFB, b-fibroblast growth factor-1, or IGF-1. It is also noteworthy that expression of at least some of these paracrine factors seems to be temporally regulated. For example, SDF-1α, after its initial robust expression 72 hours after MI, eventually became undetectable in myocardial tissue transplanted with nCPCs. The role of this temporal expression in tissue repair and the mechanism for such temporal regulation remains to be further studied. Taken together, these results suggest that the beneficial effects of transplanted nCPCs on post-MI myocardial recovery are because of paracrine pathways.
We identified that TCM is necessary to achieve the maximum potential of CPC therapy. Fractionation of TCM into exosomes and exosome-free fractions significantly compromised its angiogenic and wound-healing potential, suggesting that both exosomes and independently secreted proteins play essential roles in angiogenesis, cell proliferation, and migration. These observations were supported by ELISA of various fractions of TCM as angiogenesis inducing, and cardioprotective paracrine factors were distributed between the exosomes and exosome-free fractions. At the same protein concentration, TCM recovered ≈8% more myocardial function when compared with the exosome fraction or exosome-free fraction, which demonstrated that the fractionation of TCM into its components reduced its capacity to recover myocardial function. Recent studies have credited the cardioprotective trophic effects of different cell preparations exclusively to exosomes because of their recognized angiogenic and antiapoptotic properties. [72] [73] [74] [75] However, our hypothesis-free proteomic profiling and pathway analysis of the CPC secretome revealed many extracellular, nonexosomal proteins in both nTCM and aTCM that affect pathways essential for myocardial functional recovery. This was further underscored by our observation that pathways essential for complete cardiovascular recovery require an interactome of proteins spanning extracellular, plasma membrane, and cytosolic compartments (Figure 6E and 6F ; Table) . It will be important to determine how each of these components interact with the diversity if cell types (fibroblasts, cardiomyocytes, and endothelial cells) of the ischemic myocardium. Also, another future question is to determine whether nTCM's superior myocardial recoverability is true for other stem cell preparations and how the exosome contribution might play a role in this recovery process. Nevertheless, this study constitutes the most extensive characterization of the TCM and its components to date using an unbiased approach.
Transplanted CPCs act on recovering the ischemic myocardium by activating multiple endogenous myocardial pathways, but the mechanisms that regulate CPC's functional potential are largely unexplored. To gain deeper insight, we present results from a proteome study of the TCM of nCPCs and aCPCs. Here, we present the results of high-resolution LC-MS/MS quantitative proteome approach aimed at identifying the most highly represented proteins, differentially expressed proteins, the pathways targeted by them and the upstream regulators of the CPCs' secretomes. Taken together, these observations provide an integrated picture of the complex pathways induced by the nCPCs through the modulation of expression and activation levels of key signaling proteins.
Comparative analysis of nTCM and aTCM data sets indicates that nTCM possesses greater antioxidant and anti-inflammatory potential and supports higher protein and nucleic acid metabolism, resulting in reduced free radicals and inflammation in the infarcted myocardium and enhanced cellular proliferation and movement. However, aTCM consisted of proteins with different or even opposite effects reflecting divergent regulation and biological activities of these 2 types of chronologically cells. This finding argues for a fundamental switch of protein expression during the transition from nCPCs to aCPCs. To go beyond a simple description of protein data lists, we complemented our data analysis with localization, protein interaction, and validation of the in silico analysis with in vitro verification experiments. Therefore, our data sets provide a starting point to unravel a variety of mechanisms supporting the myocardial functional recovery potential of the CPC's secretome. The canonical signaling pathways analysis by IPA identified that myocardial recovery by nTCM is mediated by its potential to activate multiple pathways known to be cardioprotective, whereas aTCM has a limited potential. In-depth analysis of the data set identified HSPs (HSP70s and HSP90s in particular) to be highly represented in nTCM, affecting ≈20% of the canonical signaling pathways and HSF1 as one of the top upstream regulators. In vitro validation of these results proved that HSPs are indeed affected by aging as they were differentially expressed in nCPCs when compared with aCPCs. Our recent study also suggested that HSF1 is necessary and sufficient to enhance the regenerative functional activity of the secretome from cardiosphere-derived cells, but this pathway had not yet been shown to affect the secretome in human CPCs. 26 Because these potential observations strongly suggested that the heat-shock response is a powerful pathway that may govern the composition of CPCs secretome, we performed knockdown of HSF1 in nCPCs and overexpression in aCPCs to establish the extent of its control of the CPC secretome. We demonstrated that knockdown of HSF1 in nCPCs not only compromised their morphology (hypertrophic), proliferation, metabolism, and resistance to oxidative stress but also downregulated its direct or indirect target genes related to the production of cytokines, growth factors, and angiogenic proteins, resulting in a significant loss of functional activity of nTCM. Whereas overexpression of HSF1 in aCPCs rejuvenated them by enhancing their metabolism and resistance to oxidative stress. Also, the overexpression of HSF1 rescued the reparative capacity of aTCM by enriching it with higher levels of cytokines and growth factors responsible for angiogenesis and migration.
Thus, we propose that HSF1 regulates the expression of multiple proteins in the secretome of CPCs at various levels. HSF1 not only activates key upstream regulators of cytokine production (HIF1α, VEGFA, and HSPs) but also is involved in a diverse array of cellular processes, including maintenance of protein homeostasis (enhanced HSPs) and growth. 76, 77 HSPs (chaperone proteins), which are known to be under the direct regulation of HSF1, were highly represented in nTCM when compared with aTCM ( Figure 6G ), we propose that the secretome can also transmit these chaperone proteins between cells via exosomes to maintain the proteostasis of the target cells.
78
HSF1 positively affects exosome production from CPCs, which are also an active composition of the secretome.
79 HSF1 is also known to reduce the effects of aging, improve longevity, and strengthen elderly hearts against stress. [80] [81] [82] This existing evidence, in combination with our findings, implies that the secretome of aCPCs may be improved by the overexpression of HSF1 before transplantation. The modulation of HSF1 in aCPCs has the potential to directly benefit elderly patients where HSPs were minimally represented in their secretome. These results may have broad applications to optimize cardiac stem cell protocols in the future.
Although in our analysis HSPs were found to be particular mediators of the nTCM-associated myocardial recovery, we also identified other highly representative pathways known to involve antifibrotic, antiapoptotic, and proangiogenic pathways. Recent publications have identified the potential of follistatin-like-1 to facilitate post-MI recovery. 83, 84 An intriguing finding in our study is that nTCM and aTCM consists of a high amount of follistatin-like-1. In fact, follistatin-like-1 is the 16th most represented protein between the shared proteins of nTCM and aTCM (Online Table VII ). Future studies in this direction should detect true relationships to extend our analysis from these data sets to identify novel pathways of myocardial recovery.
There are many clinical implications from this study, which has the potential to influence future c-kit + CPC-based clinical trials. First, the growth properties of the c-kit + CPCs are affected by chronological age. As the cells are expanded, the aCPCs had decreased growth reserve with increasing passage number, which is in contrast to nCPCs. If aCPCs are used in future clinical trials, their growth properties need monitoring during the ex vivo expansion process, as their activity maybe directly affected. One approach to overcome these chronological age limitations of CPCs is to consider allogeneic nCPC therapy. Therefore, future detailed studies on whether the nCPCs are immune privileged, as has been shown for other stem/progenitor cells, 85, 86 are essential for clinical application of nCPCs. Second, our data show that nTCM is more effective than nCPCs or their derived exosomes. This raises the possibility that a standardized nTCM preparation could provide the basis for an off-the-shelf therapeutic option, negating the need for lengthy and costly ex vivo expansion of autologous CPCs for cell therapy. Third, identifying the essential paracrine factors may lead to a single factor or a mixture of such factors that could recapitulate the biological activity of nCPCs. March 3, 2017
In conclusion, our studies show that c-kit + CPCs repair and recover the ischemic myocardium through a robust secretion of paracrine factors that trigger and activate a variety of endogenous cardiac repair mechanisms. The magnitude of expression, composition, and biological activity of CPCs paracrine factors is dramatically affected by the chronological age of the cells. Finally, our results show that the cell-free CPC-derived secretome is sufficient for myocardial recovery and repair, raising the possibility that such cell-free preparations might be developed into standardized, safe, and effective therapies for patients having heart disease.
